skip to main content
Idioma:
Refinado por: assunto: Dispositivos Anticoncepcionais Femininos remover assunto: Síndrome Do Ovário Policístico remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome
Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome

C. Vieira W. P Martins; J. B. F Fernandes; G. M Soares; Rosana M Reis; Marcos Felipe Silva de Sá; Rui Alberto Ferriani; Annual Meeting of the European Society of Human Reproduction & Embryology (27. 2011 Stockholm)

Human Reproduction Oxford v. 26, suppl. 1, p. i31, res. P-494, 2011

Oxford 2011

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2210400 estantes deslizantes ) e outros locais(Acessar)

2
Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome
Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

G. M. Soares C. S Vieira; W. P Martins; Rosana Maria dos Reis; Marcos Felipe Silva de Sá; Rui Alberto Ferriani

International Journal of Clinical Practice Oxford v. 63, n. 1, p. 160-169, 2009

Oxford 2009

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1697225 )(Acessar)

3
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
Material Type:
Artigo 		Adicionar ao Meu Espaço

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

Carolina Sales Vieira Wellington de P Martins; Janaína Boldrini França Fernandes; Gustavo Mafaldo Soares; Rosana Maria dos Reis; Marcos Felipe Silva de Sá; Rui Alberto Ferriani

Contraception Philadelphia v. 86, n. 3, p. 268-275, 2012

Philadelphia 2012

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2329262 Estantes Deslizantes )(Acessar)

4
Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome
Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

G. M. Soares C. S Vieira; W. P Martins; Rosana Maria dos Reis; Marcos Felipe Silva de Sá; Rui Alberto Ferriani

International Journal of Clinical Practice Oxford v. 63, n. 1, p. 160-169, 2009

Oxford 2009

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1697225 )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Refinar Meus Resultados

Assunto 

  1. Sistema Cardiovascular  (1)
  2. Doenças Cardiovasculares  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.